+ 1.70
+ 0.58%
+ 0.39
+ 0.11%

Planet 13 Praises 'Solid' Q1 Despite 'Sharp' COVID-19 Related Drop-Off In Traffic

June 2, 2020 3:04 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Planet 13 Holdings (CSE:PLTH) (OTC:PLNHF) reported its first-quarter 2020 financial results.

Revenue was reported to be $16.8 million, an increase of 21.4% compared with the same quarter from 2019. Gross profit, before adjustments, reached $9 million.

The Nevada-based company reported a net loss of $1.4 million, maintaining even when compared with the same quarter of the previous financial period. Net income was disclosed to be of $300 and adjusted EBITDA was reported positive of $2.5 million with operating expenses of $7 million.

Planet 13 also reported total liquidity of $13.9 million with total assets of $66.5 million.

During this period, Planet 13 started making 24-hour delivery services and expanded its online ordering service. Another highlight of this quarter was the acquisition of a dispensary license and the company's closing a Santa Ana acquisition. 

Planet 13 co-CEO Larry Scheffler called the quarter "solid," despite a sharp COVID-19 related drop-off in traffic in the latter half of March.

"We continued to grow our market share in Nevada during the quarter, with the SuperStore accounting for 10.1% of all retail cannabis sales in the state in quarter — our best yet," Scheffler added. "Prior to the impact of COVID-19 we were heading for another record month in March at the SuperStore and expect the momentum to resume as activity in the state continues to increase.”

The company's objectives during this time have been to maintain "a solid balance sheet" while growing its local customer base, Scheffler explained.

Related Articles

The Week In Cannabis: Stocks Outperform S&P, Mexico Moves Forward, Earnings, And More

Cannabis stocks outperformed the S&P 500 this week. Over the last five trading days: read more

Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic

Global Developments in Germany, Canada and Brazil Germany has approved a large phase 2b study on psilocybin for treatment-resistant depression. read more

Cannabis Stock Gainers And Losers From November 20, 2020

Gainers: Icanic Brands (OTC: ICNAF) shares closed up 13.42% at $0.39 read more

Zuber Lawler Sits Down With Akerna CEO To Discuss Cannabis Reform Initiatives

This special presentation from Zuber Lawler comes from Benzinga’s Virtual Cannabis Capital Conference that took place on October 15. read more

U.K. Authorizes Artelo To Test Cancer Appetite Recovery Study Using Synthetic Cannabinoid

Artelo Biosciences Inc. (NASDAQ: ARTL), a San Diego, California, and Dublin, Ireland-based clinical-stage biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system, announced on Monday it received a Clinical Trial Autho read more